Antibiotics, skin and soft tissue infection and meticillin-resistant Staphylococcus aureus: cause and effect

https://doi.org/10.1016/S0924-8579(09)70542-4Get rights and content

Abstract

Staphylococcus aureus is not a new cause of skin and soft tissue infection, but the significance of the Panton-Valentine leukocidin toxin and the spread of several clones carrying different staphylococcal cassette chromosome (SCC) mecA gene cassette types have given it a new lease of life. This is a clinical area with several epidemic strains causing major problems around the world, most notably in the USA. While most attention focuses on treatment, prevention should be the goal. Traditional infection control measures, such as good hand hygiene and barrier precautions, are usually emphasised. Most importantly, we should not forget the underlying cause of meticillin-resistant Staphylococcus aureus (MRSA), namely antibiotic use. In both community and hospital, exposure to β-lactams, in particular cephalosporins, and also sometimes quinolones and macrolides, is likely to promote the transmission, colonisation and increased virulence of MRSA. Future antibiotic policies should consider this, particularly in an era of widespread MRSA screening.

References (34)

  • C Isbister et al.

    Further study of staphylococcal infection of the new-born

    Med J Aust

    (1954)
  • B An Diep et al.

    The role of virulence determinants in community associated MRSA pathogenesis

    Trends Microbiol

    (2008)
  • F Vandenesch et al.

    Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence

    Emerg Infect Dis

    (2003)
  • SYC Tong et al.

    Global implications of the emergence of community-associated methicillin-resistant Staphylococcus aureus in indigenous populations

    Clin Infect Dis

    (2008)
  • JA Lindsay et al.

    Understanding the rise of the superbug: investigation of the evolution and genomic variation of Staphylococcus aureus

    Funct Integr Genomics

    (2006)
  • Gould IM, Girvan K, Browning RA, MacKenzie FM, Edwards G. Report of a hospital neonatal unit outbreak of community...
  • JA Jernigan et al.

    Control of methicillin-resistant Staphylococcus aureus at a university hospital: one decade later

    Infect Control Hosp Epidemiol

    (1995)
  • Cited by (32)

    • Infectious flexor hand tenosynovitis: State of knowledge. A study of 120 cases

      2018, Journal of Orthopaedics
      Citation Excerpt :

      Recent epidemiologic and microbiologic research found that in France, two thirds of Staphylococcus aureus are sensitive to Augmentin (amoxicillin and clavulanic acid). On the contrary, the trend is the inverse in the United States [19,20], where two thirds of Staphylococcus aureus are resistant to Augmentin. These microbiological data allow for the administration of empirical antibiotic therapy, while definitive microbiologic results are awaited.

    • Controlling hospital MRSA

      2013, Journal of Global Antimicrobial Resistance
      Citation Excerpt :

      It is safe to conclude that without antibiotics there would be no MRSA and that the antimicrobial era has been primarily responsible for driving the rapid evolution of S. aureus since the second world war, in a truly epic battle of survival of the fittest. Even in community- and livestock-associated MRSA we see the influence of antimicrobial selection pressure [7]. Transmission of MRSA in the hospital requires a source, which is usually patients in the endemic setting and rarely staff.

    • Comparison of necrotizing fasciitis and sepsis caused by Vibrio vulnificus and Staphylococcus aureus

      2011, Journal of Bone and Joint Surgery
      Citation Excerpt :

      In the past decade, Staphylococcus aureus was reported to be the most common cultured pathogen4,6,17,18. The Panton-Valentine leukocidin (PVL) toxin and several clones carrying different staphylococcal cassette chromosome (SCC) mecA gene cassette types have been reported in association with Staphylococcus aureus skin and soft-tissue infections23–26. MRSA has been reported to have a prevalence of 59% to 75% in soft-tissue infections and 29% to 39% in necrotizing fasciitis1,2,5,8,16–19,27.

    View all citing articles on Scopus
    View full text